Fundz

FundaMental Pharma raised €12.7 million in seed funding, appoints Dr. Dirk Beher as Chief Executive Officer

PRIVATEApr 11, 2024

Amount Raised

€12.7 Million

Round Type

Seed

HeidelbergBiotechnologyHealth CareTherapeutics

Investors

Novartis Venture Fund

Description

FundaMental Pharma has appointed Dr. Dirk Beher as Chief Executive Officer and Executive Board member, taking over from co-founder Dr. Thomas Schulze. The company recently raised additional seed funding from new investor, the Novartis Venture Fund, bringing its total seed financing to €12.7 million.

Quick answer

FundaMental Pharma raised €12.7 Million in a Seed round, dated April 11, 2024. Investors: Novartis Venture Fund. FundaMental Pharma is based in Heidelberg, Baden Württemberg, Germany.

How much did FundaMental Pharma raise?
FundaMental Pharma raised €12.7 Million in a Seed round on April 11, 2024.
Who invested in FundaMental Pharma?
Novartis Venture Fund is named as investors in this round.
What does FundaMental Pharma do?
FundaMental Pharma GmbH is a neuroscience company spun out of Heidelberg University, dedicated to developing first-in-class small molecule inhibitors for the treatment of a range of neurodegenerative diseases.
Where is FundaMental Pharma based and how big is it?
FundaMental Pharma is based in Heidelberg, Baden Württemberg, Germany.
Who are the decision-makers at FundaMental Pharma?
Fundz holds 1 contact at FundaMental Pharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as FundaMental Pharma that raised within 45 days of this round, from Fundz verified event records.

  • Bicycle Therapeutics raised $555M (Post-IPO Equity) on May 23, 2024.
  • Grey Wolf Therapeutics raised $50M (Series B) on May 23, 2024.
  • Pheon Therapeutics raised $120M (Series B) on May 21, 2024.
  • YGION Biomedical raised $16M (Series A) on May 21, 2024.
  • Limula raised $6.8M (Seed) on May 21, 2024.
  • AltruBio Inc. raised $225M (Series B) on May 21, 2024.

Who to call at FundaMental Pharma, and when

A new round usually means FundaMental Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day FundaMental Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at FundaMental Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at FundaMental Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

FundaMental Pharma

Location

Heidelberg, Baden Württemberg, Germany

About

FundaMental Pharma GmbH is a neuroscience company spun out of Heidelberg University, dedicated to developing first-in-class small molecule inhibitors for the treatment of a range of neurodegenerative diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment FundaMental Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for FundaMental Pharma's next move

See what Strategic adds

FundaMental Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.